These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6177115)

  • 1. [Kallikreinogen determination in the plasma of various species].
    Lehmann B; Kühne H; Scheuch DW
    Z Med Lab Diagn; 1981; 22(6):354-5. PubMed ID: 6177115
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of heparin on the activation of kallikreinogen in human plasma].
    Lehmann B; Scheuch DW
    Z Med Lab Diagn; 1981; 22(6):356-7. PubMed ID: 6919337
    [No Abstract]   [Full Text] [Related]  

  • 3. Prekallikein and kallikrein inhibitor in liver cirrhosis and hepatitis.
    Faciullacci M; Galli P; Monetti MG; Pela I; Del Bianco PL
    Adv Exp Med Biol; 1976; 70(00):201-8. PubMed ID: 1084679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein.
    Kluft C
    J Lab Clin Med; 1978 Jan; 91(1):83-95. PubMed ID: 618993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallikreinogen-kallikrein enzymatic system in human plasma. Spontaneous and after activation pool determination in healthy boys, through the use of a new kit.
    Vecchiet L; Cacchio M; Cristiano E; Del Boccio G
    Boll Soc Ital Biol Sper; 1979 Jan; 55(1):27-31. PubMed ID: 475914
    [No Abstract]   [Full Text] [Related]  

  • 6. Dextran-induced lowering of parameters of the kallikrein-kinin system in rat plasma.
    Briseid K; Johansen R; Rustenberg L
    Adv Exp Med Biol; 1979; 120B():101-12. PubMed ID: 517228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterization of shock sensitivity in experimental hemorrhagic shock (5,3 and 8,0 kPa) by determining kallikrein, kallikreinogen, non-specific proteases and inhibitor capacity of blood plasma].
    Kühne H; Lehmann B; Taucher M; Scheuch DW
    Z Med Lab Diagn; 1983; 24(3):123-8. PubMed ID: 6351457
    [No Abstract]   [Full Text] [Related]  

  • 8. [Activation of kallikreinogens in blood plasma after experimental endotoxin poisoning in juvenile pigs].
    Kühne H; Lehmann B; Scheuch DW
    Arch Exp Veterinarmed; 1986 Jul; 40(4):571-4. PubMed ID: 3639731
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pattern of serum kallikreinogen-kallikrein system in patients with goiter].
    Doliński J; Bielicki F; Lukieńczuk T; Witkiewicz W; Koziorowski A
    Endokrynol Pol; 1978; 29(1):31-4. PubMed ID: 580605
    [No Abstract]   [Full Text] [Related]  

  • 10. [Enzyme activity (monoamine oxidase, histaminase, kallikreinogen) in carcinoids treated with parachlorophenylalanine].
    Fanciullacci M; Curradi C; Di Lollo F; Sicuteri F
    Boll Soc Ital Biol Sper; 1975 Sep; 51(17):1025-30. PubMed ID: 130150
    [No Abstract]   [Full Text] [Related]  

  • 11. Observations on the plasma kallikreinogen (prekallikrein)-kallikrein enzyme system.
    Sherry S; Colman RW
    Trans Assoc Am Physicians; 1968; 81():40-8. PubMed ID: 5305252
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma total prekallikrein/kallikrein activity in rheumatoid arthritis with and without amyloidosis. Increased kaolin-stimulated activity in patients with amyloidosis.
    Teppo AM; Pakkanen R; Maury CP
    Acta Med Scand; 1985; 217(4):397-402. PubMed ID: 2409750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine and kallikrein system in man.
    Pedata F; Del Bianco PL; Curradi C; Anselmi B; Sicuteri F
    Adv Exp Med Biol; 1976; 70(00):229-34. PubMed ID: 1084681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prekallikrein-Kallikrein conversion rate as a predictor of contrast material catastrophies.
    Lasser EC; Lang JH; Lyon SG; Hamblin AE; Howard MM
    Radiology; 1981 Jul; 140(1):11-5. PubMed ID: 6166025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kallikreinogen-kallikrein system in the blood of patients with vascular complications of diabetes].
    Kaniak J; Kotschy M; Kurzawska M; Ciosek W
    Pol Tyg Lek; 1977 May; 32(19):705-7. PubMed ID: 866255
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
    Kallen RJ; Lee SK
    Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of prekallikrein in the cases with disseminated intravascular coagulation syndrome.
    Sakuragawa N; Takahashi K; Shibata A
    Adv Exp Med Biol; 1979; 120B():185-93. PubMed ID: 160191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kallikreinogen-kallikrein system during muscular work in patients with intermittent claudication: influence of tauring treatment.
    Franchi G; Fanciullacci M; Curradi C; Nuzzaci G; Monetti MG; Caternolo M
    Adv Exp Med Biol; 1976; 70(00):323-7. PubMed ID: 937138
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of the kallikrein-kinin system in bullet wounding.
    Lewis DH; Bengtsson MB; Larsson J; Liljedahl SO
    Acta Chir Scand Suppl; 1979; 489():225-30. PubMed ID: 291259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved methods to assay contact activation.
    Soulier JP; Gozin D
    Adv Biosci; 1978 Jul; 17():271-80. PubMed ID: 755703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.